Related Experiment Video
Updated: Jun 18, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
Design, synthesis, molecular docking and in vitro anticancer activities of 1-(4-(benzamido)phenyl)-3-arylurea
Prafulla Sabale1, Nusrat Sayyad1, Abuzer Ali2
1Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University Mahatma Jyotiba Fuley Shaikshanik Parisar Nagpur-440033 India prafullasable@yahoo.com nusratsayyad11@gmail.com +919158537050.
Abstract:
In both premenopausal and postmenopausal women, oestrogens play a critical role in the development of breast cancer. Aromatase is an enzyme that catalyses the final step in the biosynthesis of estrogen and has emerged as a promising target for therapeutic intervention. This study aimed to design and evaluate novel 1-(4-(benzamido)phenyl)-3-arylurea derivatives as potential aromatase inhibitors. Through molecular docking, promising leads were identified and synthesized. Spectroscopic techniques confirmed their structural integrity. Cytotoxicity against various cancer cell lines was assessed using MTT assay. Docking investigations against the aromatase enzyme (3s7s) elucidated binding interactions and energies. Compound 6g, exhibiting a binding energy of -8.6 kcal mol-1 and interacting with ALA306 and THR310 residues, showed the most promising activity. It demonstrated GI50 values ranging from 14.46 μM, 13.97 μM, 11.35 μM, 11.58 μM, and 15.77 μM against A-498, NCI-H23, MDAMB-231, MCF-7, and A-549 respectively. Lastly, the physicochemical, and ADMET properties of the compound were predicted. These findings highlight the potential of 1-(4-(benzamido)phenyl)-3-arylureas as a new class of antitumor agents targeting aromatase. Their versatility and superior activity compared to standard chemotherapeutic agents, like doxorubicin, warrant further investigation for the development of broader-spectrum anticancer drugs.
Insights
Novel 1-(4-(benzamido)phenyl)-3-arylurea derivatives were designed as potential aromatase inhibitors for breast cancer therapy. Compound 6g demonstrated significant antitumor activity, showing promise as a new class of anticancer agents.
Area of Science:
- Medicinal Chemistry
- Oncology
- Biochemistry
Background:
- Estrogens are critical in breast cancer development for both premenopausal and postmenopausal women.
- Aromatase enzyme, crucial for estrogen biosynthesis, is a key therapeutic target.
Purpose of the Study:
- To design and evaluate novel 1-(4-(benzamido)phenyl)-3-arylurea derivatives as potential aromatase inhibitors.
- To identify potent compounds for breast cancer treatment targeting aromatase.
Main Methods:
- Molecular docking simulations to identify lead compounds.
- Synthesis and structural confirmation using spectroscopic techniques.
- Cytotoxicity assessment via MTT assay against various cancer cell lines.
- In silico prediction of physicochemical and ADMET properties.
Main Results:
- Compound 6g exhibited a strong binding energy (-8.6 kcal mol⁻¹) with aromatase (3s7s), interacting with key residues.
- Compound 6g displayed potent GI₅₀ values across multiple cancer cell lines (e.g., 11.35 μM for MDAMB-231).
- Predicted physicochemical and ADMET properties suggest favorable drug-likeness for compound 6g.
Conclusions:
- 1-(4-(benzamido)phenyl)-3-arylureas represent a promising new class of aromatase inhibitors.
- Compound 6g shows significant potential as an antitumor agent, warranting further investigation for broader-spectrum anticancer drug development.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
Physical Properties of Amines
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...

